The Association of Nine Novel Variants in the ZEB2 Gene with Serum Levels of TNF-α, TGF-β and IFN-γ

Zahraa Hashim Rabae, Jawdat Noori Gaaib

Abstract


Background: ZEB1 and ZEB2, are expressed by a variety of immune cells of both myeloid and lymphoid lineages, they act to regulate important transcriptional networks necessary for cell differentiation, maintenance, and function. The study was carried out in the Department of Clinical Laboratories / College of Applied Medical Sciences / University of Kerbala during the period from January 2021 to September 2021. The study aimed to shed light on the association between the variation of the ZEB2 gene and serum levels of some cytokines (TNF-α, TGF-β, INF-γ) involved in immune cell differentiation in the Iraqi population.

Methods: A total of 80 healthy volunteers, randomly chosen, were enrolled in this study, with an age ranged 20-50 years at the time of the investigation. The variation of the ZEB2 gene was investigated by the Sanger sequencing method. The serum levels of TNF-α, TGF-β and INF-γ were measured by ELISA.

Results: The results identified presence of nine novel non-registered variants in 27 samples, 5 out of 9 variants were detected in exon1 region, while the other 4 were detected in the 5`UTR region. These variants might be of interest to the ZEB2 gene studies due to their presence in the coding and regulatory regions that regulate the gene expression.

Conclusion: The two variants, 144520053 G/A and 144520162 T/A, among the nine novel variants might be the most important variants because both showed significant effects on some study parameters.

Keywords: Novel variants; ZEB2; TNF-alpha; TGF- beta; IFN-gamma 


Full Text:

PDF

References


Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions. Nucleic acids research, (2005); 33(20): 6566-6578.

Wiles ET, Bell R, Thomas D, Beckerle M, Lessnick SL. ZEB2 represses the epithelial phenotype and facilitates metastasis in Ewing sarcoma. Genes & cancer, (2013); 4(11-12): 486-500.

Wang J, Farkas C, Benyoucef A, Carmichael C, Haigh K, et al. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity. PLoS biology, (2021); 19(9): e3001394.

Scott CL, Omilusik KD. ZEBs: novel players in immune cell development and function. Trends in immunology, (2019); 40(5): 431-446.

Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature reviews cancer, (2007);

(6): 415-428.

Wang J, Lee S, Teh CE-Y, Bunting K, Ma L, et al. The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells. International immunology, (2009); 21(3): 227-235.

Sánchez-Tilló E, Siles L, De Barrios O, Cuatrecasas M, Vaquero EC, et al. Expanding roles of ZEB factors in tumorigenesis and tumor progression. American journal of cancer research, (2011); 1(7): 897.

Stankiewicz TR, Gray JJ, Winter AN, Linseman DA. C-terminal binding proteins: central players in development and disease. Biomolecular concepts, (2014); 5(6): 489-511.

Deverman BE, Patterson PH. Cytokines and CNS development. Neuron, (2009); 64(1): 61-78.

Gulati K, Guhathakurta S, Joshi J, Rai N, Ray A. Cytokines and their role in health and disease: a brief overview. MOJ Immunology, (2016); 4(2): 1-9.

Zidek Z, Anzenbacher P, Kmoníčková E. Current status and challenges of cytokine pharmacology. British journal of pharmacology, (2009); 157(3): 342-361.

Tato CM, Cua DJ. SnapShot: cytokines II. Cell, (2008); 132(3): 500. e501-500. e502.

Hamilton SE, Jameson SC (2015) Effective effector generation of CD8+ T cells and NK cells: a need for T-bet and ZEB-too. The Rockefeller University Press.

Li J, Riedt T, Goossens S, Carrillo García C, Szczepanski S, et al. The EMT transcription factor ZEB2 controls adult murine hematopoietic differentiation by regulating cytokine signaling. Blood, The Journal of the American Society of Hematology, (2017); 129(4): 460-472.

Vandewalle C, Van Roy F, Berx G. The role of the ZEB family of transcription factors in development and disease. Cellular and molecular life sciences, (2009); 66(5): 773-787.

Craene BD, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nature Reviews Cancer, (2013); 13(2): 97-110.

Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, et al. TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity, (2004); 21(4): 491-501.

Dominguez CX, Amezquita RA, Guan T, Marshall HD, Joshi NS, et al. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. Journal of Experimental Medicine, (2015); 212(12): 2041-2056.

Zou D, Wang L, Wen F, Xiao H, Duan J, et al. Genotype phenotype analysis in Mowat Wilson syndrome associated with two novel and two recurrent ZEB2 variants. Experimental and therapeutic medicine, (2020); 20(6): 1-1.

Hu Y, Peng Q, Ma K, Li S, Rao C, et al. A novel nonsense mutation of ZEB2 gene in a Chinese patient with Mowat‐Wilson syndrome. Journal of Clinical Laboratory Analysis, (2020); 34(9): e23413.

Ghoumid J, Drevillon L, Alavi-Naini SM, Bondurand N, Rio M, et al. ZEB2 zinc-finger missense mutations lead to hypomorphic alleles and a mild Mowat–Wilson syndrome. Human molecular genetics, (2013); 22(13): 2652-2661.

McKenna K, Beignon A-S, Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. Journal of virology, (2005); 79(1): 17-27.

Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, et al. Deciphering the transcriptional network of the dendritic cell lineage. Nature immunology, (2012); 13(9):

-899.

Cenik C, Derti A, Mellor JC, Berriz GF, Roth FP. Genome-wide functional analysis of human 5'untranslated region introns. Genome biology, (2010); 11(3): 1-17.

Mignone F, Gissi C, Liuni S, Pesole G. Untranslated regions of mRNAs. Genome biology, (2002); 3(3): 1-10.

De Angioletti M, Lacerra G, Sabato V, Carestia C. β+ 45 G→ C: a novel silent β‐thalassaemia mutation, the first in the Kozak sequence. British journal of haematology, (2004); 124(2): 224-231.

Pichon X, A Wilson L, Stoneley M, Bastide A, A King H, et al. RNA binding protein/RNA element interactions and the control of translation. Current Protein and

Peptide Science, (2012); 13(4): 294-304.




DOI: http://dx.doi.org/10.62940/als.v9i2.1373

Refbacks

  • There are currently no refbacks.